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Abstract
Background: The Questionnaire of Olfactory Disorders-Negative Statements
(QOD-NS) is a 17-item instrument measuring olfactory-specific quality of life
(QOL). However, in clinical research patients can be overwhelmed with multiple questionnaires. We recently developed the 7-item brief QOD-NS (B-QOD).
Our objective was to evaluate the psychometric properties of the B-QOD in both
the development (D) sample, and in a separate replication (R) sample.
Methods: Testing on D (n = 203) and R (n = 281) samples included initial
exploratory factor analysis (EFA), followed by internal reliability, information
loss, and confirmatory factor analysis (CFA). Finally, incremental predictive utility analysis (IPUA) was performed by correlating the B-QOD with the 22-item
Sino-Nasal Outcome Test (SNOT-22) survey.
Results: EFAs of both D and R demonstrated an underlying single-factor structure (eigenvalue = 4.17 and 3.57, respectively) with comparable loading factors
(R > 0.30 for both). B-QOD also had good internal reliability in both D and R
(Cronbach’s alpha = 0.88 and 0.83, respectively). Also, there is minimal information loss with B-QOD compared to QOD-NS in both D and R (R = 0.98 and 0.96,
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respectively). CFA indicates that the B-QOD single-factor model has good overall
fit as measured by the Comparative Fit Index (CFI) and the Standardized Root
Mean Squared Residuals (SRMSR) in the D and R samples (CFI = 0.99 and 0.97;
SRMSR = 0.035 and 0.053). IPUA shows that the QOD-NS offers no additional
predictive benefit of SNOT-22 scores when compared with B-QOD.
Conclusion: The 7-item B-QOD captures a structurally coherent and reliable
single dimension, with minimal information loss and excellent external predictive utility when compared to the QOD-NS.
KEYWORDS

olfaction disorders, patient reported outcome measures, quality of life, sinusitis, smell

INTRODUCTION

SUBJECTS AND METHODS

Chronic rhinosinusitis (CRS) is a common inflammatory disorder affecting ∼5% to 16% of North American
populations.1 Symptoms of CRS are nasal congestion, discolored nasal drainage, facial pain/pressure, and olfactory
dysfunction (OD), with OD estimated to affect between
40% and 80% of CRS patients in certain study populations.2
OD ranks as the second most important symptom for CRS
patients after nasal congestion,3 and consequently has garnered significant attention in quality of life (QOL) and outcomes research. This has led to the development of instruments that specifically focus on olfactory-specific QOL.4–6
In particular, the questionnaire of olfactory disorders negative statements (QOD-NS) is a 17-item validated instrument in the measurement of olfactory-specific QOL, and
also demonstrates robust psychometric properties.7,8
However, in the clinical and outcomes research setting, patients are frequently inundated with a variety of
questionnaires and instruments to complete, and the time
required to complete these instruments can be significant. Furthermore, shorter patient-reported outcome metrics (PROMs) have been shown to lead to increased efficiency, reduced patient burden, and greater data quality.9
For these reasons, we have previously developed a brief
version of the QOD-NS (B-QOD).10 The B-QOD was created to intentionally represent all of the subdomains of the
QOD-NS, and the B-QOD demonstrates excellent correlation with the total and subdomain scores of the QOD-NS
and consists of only seven items which are a subset of the
QOD-NS.10 Our present objective was to evaluate the psychometric properties of the B-QOD in the CRS population
using the initial development sample and also in a separate replication sample. In the remainder, we refer to these
samples as the development sample (D) and the replication
sample (R), respectively.

Sample populations
The purpose of these analyses was to evaluate the psychometric properties of the B-QOD using the initial D
sample (enrollment years: 2011–2016; n = 203) and in the
R sample (enrollment years: 2016–2019; n = 281). Study
enrollment originated from two observational, prospective
research investigations of human subjects funded by the
National Institute on Deafness and Other Communication
Disorders (NIDCD, Bethesda, MD, USA). Study participants were recruited at varying times from heterogeneous
patient populations presenting to academic, rhinology
centers located in North America: Oregon Health &
Science University (Portland, OR, USA), the Medical
University of South Carolina (MUSC, Charleston, SC,
USA), Stanford University (Palo Alto, CA, USA), the University of Utah (Salt Lake City, UT, USA), the University
of Colorado (Aurora, CO, USA), the University of Calgary
(Calgary, Alberta, Canada), and the University of Virginia
(Charlottesville, VA, USA). The Institutional Review
Board at each performance site provide ethical review and
oversight of this minimal risk study. Table 1 provides the
demographic and disease-specific characteristics of these
cohorts.
Symptomatic, adult study participants received a
confirmed diagnosis of symptomatic and medically recalcitrant CRS, with nasal polyposis (CRSwNP) or without
nasal polyposis (CRSsNP), from a fellowship-trained
rhinologist following criteria established by current practice guidelines.11 Participants presented with symptoms
including, but not limited to, nasal congestion, mucopurulent drainage, facial pain/pressure, and olfactory impairment. All patients provided written, informed consent to
ensure voluntary participation for this minimal risk study.
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TA B L E 1

Demographic and disease-specific characteristics of the D and R samples

Characteristics

Sample D
(n = 203)

Sample R
(n = 281)

Test statistic

p

Age (years), mean ± SD

50.5 ± 15.8

49.5 ± 16.6

t = 0.62

0.538

Male, n (%)

93 (47)

136 (49)

χ2 = 0.04

0.850

Female, n (%)

102 (51)

144 (51)

White/Caucasian, n (%)

168 (84)

249 (89)

χ2 = 3.39

0.066

African American, n (%)

14 (7)

22 (8)

χ2 = 0.15

0.699

Asian, n (%)

8 (4)

5 (2)

χ2 = 2.11

0.147

Hispanic/Latino, n (%)

11 (6)

17 (6)

χ2 = 0.04

0.845

Prior ESS, n (%)

120 (62)

124 (44)

χ2 = 13.70

<0.001

Nasal polyposis, n (%)

76 (39)

148 (53)

χ2 = 8.89

0.003

88 (45)

125 (45)

χ = 0.01

0.917

12.0 ± 6.1

13.2 ± 5.6

t = −2.16

0.031

Lund-Kennedy endoscopy score, mean ± SD

5.6 ± 3.8

6.9 ± 3.7

t = −3.43

0.001

BSIT total score, mean ± SD

8.0 ± 3.0

–

–

–

SIT total score, mean ± SD

27.6 ± 9.6

–

–

–

–

23.0 ± 9.4

–

–

QOD-NS total score, mean ± SD

14.4 ± 12.9

13.4 ± 10.7

t = 0.93

0.478

SNOT-22 total score, mean ± SD

53.4 ± 21.7

46.1 ± 21.1

t = 3.70

<0.001

Asthma, n (%)
Lund-Mackay CT score, mean ± SD

Sniffin’ Sticks TDI score, mean ± SD

2

Abbreviations: BSIT, Brief Smell Identification Test; CT, computed tomography; D, development; ESS, endoscopic sinus surgery; QOD-NS, Questionnaire of
Olfactory Disorders–Negative Statements; R, replication; SD, standard deviation; SIT, Smell Identification Test; SNOT-22, 22-item Sino-Nasal Outcome Test; TDI
score, threshold discrimination and identification composite score.

Exclusion criteria
Study participants were excluded from final cohort selection if they failed to complete QOD-NS sample survey evaluations at the time of study enrollment. Additionally, any
study participants with comorbid primary ciliary dyskinesia or cystic fibrosis (CF) were excluded due to possible disparity in disease presentation and/or treatment approach.

Analytic strategy and biostatistics
First, we performed exploratory factor analyses using the
B-QOD data from the two samples in order to examine
the number of underlying constructs that the B-QOD
might be representing, with the hypothesis that the BQOD represents a single factor. We present standardized
factor loadings, which estimate the correlation between
the underlying factor and the items; residual variances
estimate the variance in item scores not attributable to the
underlying factor. An item is deemed a “salient” indicator
if the standardized factor loading for that item exceeds
|0.32| because the factor “explains” >10% of the variance in
the item; items with loadings greater than 0.71, 0.63, and
0.55 are considered “excellent,” “very good,” and “good,”
respectively.12 We then checked the internal consistency

and reliability of the estimates achieved by the B-QOD.
To do this, we used Cronbach’s alpha. Nunnally and
Bernstein13 provide guidelines for judging the adequacy of
reliability estimates stating that estimates exceeding 0.70
are considered adequate for use in research and estimates
exceeding 0.80 are considered good. Interested readers
desiring to learn more about psychometric analysis
and the statistics involved could consult Nunnally and
Bernstein’s13 and McDonald’s14 books on the topic.
Next we explored the degree of possible information loss
between the B-QOD and the QOD-NS. Because the B-QOD
is based on seven of the 17 items in the QOD-NS it is possible that in using fewer than half of the original items, the
B-QOD may omit important information from overall scale
scores using all 17 items. To evaluate the degree of information loss, we correlated scores between the full 17-item
measure with the 7-item B-QOD.
After these steps, a confirmatory factor analysis (CFA)
model is needed to evaluate the single-factor hypothesis
directly. For this end, we used the CFA model for ordinal
indicators in Mplus software.15 We then utilized the
comparative fit index (CFI), which indicates good fit
when values exceed 0.95;16 the root mean square error of
approximation (RMSEA) indicates good fit with values
<0.05 and poor fit with values >0.1016 ; the standardized
root mean square residual (SRMR) indicates good fit when
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T A B L E 2 Standardized factor loadings for B-QOD items in the
D sample and R sample from exploratory factor analysis models
Item

Sample D

Sample R

QOD-NS 1 “Restaurants”

0.74

0.70

QOD-NS 13 “Worried”

0.65

0.60

QOD-NS 27 “Relax”

0.69

0.69

QOD-NS 33 “Isolated”

0.77

0.67

QOD-NS 37 “Eat less”

0.69

0.50

QOD-NS 42 “Daily activities”

0.79

0.73

QOD-NS 49 “Angry”

0.76

0.67

Abbreviations: B-QOD, Brief Questionnaire of Olfactory Disorders; D, development; QOD-NS, Questionnaire of Olfactory Disorders–Negative Statements;
R, replication.

values are <0.05. We also calculated standardized factor
loadings from the confirmatory analysis on both samples.
Finally, we performed an analysis of incremental predictive utility of the QOD-NS compared to the B-QOD
scores for a common QOL measure in the CRS literature,
the 22-item Sino-Nasal Outcome Test (SNOT-22).17 First,
we descriptively computed and compared the correlations
between QOD-NS and B-QOD scores with SNOT-22 total
scale scores in the D and R to test whether QOD-NS scores
have additional incremental predictive utility in the prediction of SNOT-22 total scores, a hierarchical linear regression approach was used. In the first step, SNOT-22 total
scores were regressed on B-QOD scores; in the second step,
QOD-NS scores were added as a predictor to the model.
The statistic of interest is the change in R2 from step 1 to
step 2.

RESULTS

T A B L E 3 Cronbach’s alpha internal consistency reliability
estimates for the B-QOD in the D sample and R sample
Item
Cronbach’s alpha

Sample D

Sample R

0.88

0.83

Abbreviations: B-QOD, Brief Questionnaire of Olfactory Disorders; D, development; R, replication.

T A B L E 4 Correlation between the QOD-NS scores and B-QOD
scores in the D sample and R sample
Item
Correlation

Sample D

Sample R

0.98*

0.96*

Abbreviations: B-QOD, Brief Questionnaire of Olfactory Disorders; D, development; QOD-NS, Questionnaire of Olfactory Disorders–Negative Statements;
R, replication.
*p < 0.05.

Internal consistency reliability estimates
Given that the EFAs strongly support the single-factor
structure of the B-QOD, we next turn to how reliably these
items measure that single latent dimension. Table 3 provides the Cronbach’s alpha estimates for the two samples.
The reliability estimates for the B-QOD far exceed the criterion value considered good in both samples.

Information loss between the QOD-NS and
B-QOD
Table 4 provides these correlations for the two samples
between QOD-NS and B-QOD scores. These correlations
should be considered very large and suggest that little
information is lost when using the B-QOD rather than all
17 of the QOD-NS items.

Exploratory factor analyses
The two exploratory factor analyses (EFAs) yielded similar results about the underlying structure of the B-QOD.
Globally, both EFAs exhibited a single, dominant dimension of variability for the underlying factor structure with
only a single eigenvalue greater than one (sample D 1st
eigenvalue = 4.17; sample R 1st eigenvalue = 3.57). Table 2
provides the standardized factor loadings from the EFAs
for the two samples. The standardized factor loadings are
substantively similar in size across the two samples. As
would be expected, the standardized factor loadings tend
to be a larger in D, which illustrates the importance of evaluating psychometric properties on an independent sample
over and above the development sample. Despite this slight
attenuation, the standardized factor loadings in sample R
are all sizable and far exceed the threshold for a salient
loading (i.e., a loading of 0.30 or greater).

CFA of the B-QOD items
The fit statistics for the models, along with the CFI, SRMR,
and RMSEA statistics in the two samples appear in Table 5.
T A B L E 5 Fit statistics for confirmatory factor analysis model
with categorical indicators for the B-QOD in the D and R samples
Item
Chi-square statistic (DF)

Sample D

Sample R

21.14 (11)

39.54 (12)

CFI

0.991

0.967

RMSEA

0.067

0.090

SRMR

0.035

0.053

Abbreviations: B-QOD, Brief Questionnaire of Olfactory Disorders; CFI, comparative fit index; D, development; DF, model degrees of freedom; R, replication; RMSEA, root mean square error of approximation; SRMR, standardized
root mean square residual.
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T A B L E 6 Standardized factor loadings for B-QOD items in the D sample and R sample from single-factor confirmatory factor analysis
models with categorical indicators
Item

Loading (SE)

Sample D
Residual variance

Loading (SE)

Sample R
Residual variance

QOD-NS 1 “Restaurants”

0.842 (0.036)

0.291

0.804 (.038)

0.353

QOD-NS 13 “Worried”

0.767 (0.045)

0.412

0.703 (.046)

0.505

QOD-NS 27 “Relax”

0.804 (0.041)

0.353

0.805 (.040)

0.352

QOD-NS 33 “Isolated”

0.859 (0.033)

0.262

0.778 (.040)

0.395

QOD-NS 37 “Eat Less”

0.772 (0.045)

0.404

0.616 (.054)

0.620

QOD-NS 42 “Daily activities”

0.882 (0.031)

0.222

0.824 (.032)

0.321

QOD-NS 49 “Angry”

0.851 (0.035)

0.276

0.771 (.040)

0.405

Abbreviations: B-QOD, Brief Questionnaire of Olfactory Disorders; D, development; QOD-NS, Questionnaire of Olfactory Disorders–Negative Statements; R,
replication; SE, standard error.

T A B L E 7 Correlation between the QOD-NS scores and B-QOD
scores and SNOT-22 total scores in the D sample and R sample
Sample D
SNOT-22 total
scores

Sample R
SNOT-22 total
scores

QOD-NS scores

0.42*

0.37*

B-QOD scores

0.40*

0.38*

Item

Abbreviations: B-QOD, Brief Questionnaire of Olfactory Disorders; D, development; QOD-NS, Questionnaire of Olfactory Disorders–Negative Statements;
R, replication; SNOT-22, 22-item Sino-Nasal Outcome Test.
*p < 0.05.

Overall, these results suggest that the single-factor hypothesis for B-QOD is a useful approximation to the data. Given
the adequate level of fit of the model, we now evaluated the
standardized factor loadings from the CFA models in both
samples. These are presented in Table 6. These loadings are
all large in size indicating that each item strongly relates to
the underlying single factor.

Analysis of incremental predictive utility of
QOD-NS over B-QOD
Table 7 displays the correlations between QOD-NS and BQOD scores with SNOT-22 scores in both samples; we note
that these correlations are similar in magnitude. These correlations provide evidence of the criterion-related validity of the QOD-NS and the B-QOD. For the assessment
of incremental predictive utility, QOD-NS scores did not
significantly increase the variance explained in SNOT22 scores [ΔR2 = 0.014, F(1,200) = 3.376, p = 0.068]
in D when B-QOD is controlled for statistically; similarly, in R, QOD-NS scores did not significantly increase
the variance explained in SNOT-22 scores [ΔR2 < 0.001,
F(1,277) = 0.046, p = 0.830] when B-QOD is controlled
for statistically. Thus, we conclude that QOD-NS scores
offer no statistically significant benefit in the prediction of

SNOT-22 total scores over and above the information available from the B-QOD.

DISCUSSION
We have previously reported on our development of the
B-QOD,10 which is a subset of seven items from the original QOD-NS. Our initial report confirmed that the B-QOD
purposefully included all of the subdomains of the original
QOD-NS, and B-QOD scores have good correlation with
total QOD-NS scores as well as the subdomains scores that
are captured by the QOD-NS.7,10 Furthermore, the QODNS has been previously validated in CRS patients, and this
validation included CRS patients along the entire spectrum of olfactory ability.18 As such, we maintain a similar approach to the creation and validation of the B-QOD
in CRS patients ranging from normosmics to anosmics.
However, given the substantial reduction in the number
of items from the QOD-NS to the B-QOD, it is possible that
the shortened instrument may not have all of the desired
psychometric properties. Psychometric properties refer to
the validity and reliability of a measurement tool.13 A valid
tool is one that measures what is says it is going to measure,
whereas a reliable tool consistently measures the same
construct.
Our analysis has shown that the B-QOD is both valid
and reliable. The B-QOD has good internal validity, as
shown by the exploratory and confirmatory factor analyses demonstrating a single unified construct (Tables 2, 5,
and 6). Furthermore, our results show that there is no loss
of information when comparing the B-QOD to the original QOD-NS (Table 4). The external validity of the B-QOD
is confirmed by our analysis demonstrating good correlations with SNOT-22 scores, and the fact that the original
QOD-NS does not add any predictive utility to SNOT-22
scores when compared to the B-QOD (Table 7). Furthermore, the Cronbach’s alpha analysis confirms the internal
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consistency and reliability of the B-QOD (Table 3). It is
important to note that the results hold true both in the original cohort used to develop the B-QOD, but also notably
in an entirely separate replication cohort. The consistent
findings between the performance of the B-QOD in two
independent cohorts add further evidence that this instrument is valid and reliable and should be considered for use.
The B-QOD is likely most useful for situations where
there is little time for patient to completely questionnaire
(i.e., a busy clinical setting) or where patients may be
overburdened by numerous surveys or questionnaires (i.e.,
prospective clinical research settings). In reality, the majority of patients or research subjects are likely encompassed
by these two scenarios, and so we expected that the BQOD could be useful for a wide variety of future projects
or investigations. However, some investigators may desire
the greater granularity that the original QOD-NS allows,
particularly the ability to study the different subdomains
or factors captured by the QOD-NS.7
This study has several limitations. First, the participants
in both D and R were all CRS patients, and it is possible that the instruments psychometric properties may be
different in different populations. Also, the participants
had high associated disease severity and were assessed
through tertiary practices, and therefore these results may
not be externally generalizable to all CRS patients. Further validation and study of our shortened version in other
populations with different etiologies for olfactory dysfunction (i.e., again, postinfectious, posttraumatic, etc.) of the
will be necessary to further confirm its clinical utility and
validity.

CONCLUSION
The results of this psychometric investigation indicate that
data from B-QOD capture a structurally coherent single
latent dimension, that the B-QOD reliably measures this
dimension, that little information is lost when using the
seven items of the B-QOD relative to using all 17 items of
the QOD-NS, and that the B-QOD has excellent external
predictive utility when compared to the QOD-NS. In settings where olfactory-specific QOL is of interest but survey
burden is a concern, or where rapid completion of PROMs
is of interest, the B-QOD should be considered for use due
to its few items and excellent psychometric properties.

CONFLICTS OF INTEREST
Zachary M. Soler: Olympus, OptiNose, Regeneron,
Healthy Humming, and Novartis, consultant (not affiliated with this study). Jeremiah A. Alt: Medtronic and

GlycoMira Therapeutics, consultant (not affiliated with
this study). Rodney J. Schlosser: OptiNose, Olympus,
Stryker, Regeneron, and Healthy Humming, consultant
(not affiliated with this study). Vijay R. Ramakrishnan:
OptiNose and Medtronic, Inc, consultant (not affiliated with this study). Daniel M. Beswick: Medtronic,
consultant (not affiliated with this study).
ORCID
Jose L. Mattos MD, MPH https://orcid.org/0000-00018766-1626
Daniel M. Beswick MD https://orcid.org/0000-00018612-5442
Spencer C. Payne MD https://orcid.org/0000-0001-97364561
Timothy L. Smith MD, MPH https://orcid.org/00000002-6424-7083
REFERENCES
1. Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: a systematic review. Laryngoscope. 2015;125(7):1547-1556.
2. Soler ZM, Smith TL, Alt JA, Ramakrishnan VR, Mace JC,
Schlosser RJ. Olfactory-specific quality of life outcomes
after endoscopic sinus surgery. Int Forum Allergy Rhinol.
2016;6(4):407-413.
3. Mattos JL, Rudmik L, Schlosser RJ, et al. Symptom importance,
patient expectations, and satisfaction in chronic rhinosinusitis.
Int Forum Allergy Rhinol. 2019;9(6):593-600.
4. Soler ZM, Kohli P, Storck KA, Schlosser RJ. Olfactory impairment in chronic rhinosinusitis using threshold, discrimination,
and identification scores. Chem. Senses. 2016;41(9):713-719.
5. DeConde AS, Mace JC, Alt JA, Schlosser RJ, Smith TL, Soler
ZM. Comparative effectiveness of medical and surgical therapy on olfaction in chronic rhinosinusitis: a prospective, multiinstitutional study. Int Forum Allergy Rhinol. 2014;4(9):725-733.
6. Patel ZM, Thamboo A, Rudmik L, Nayak JV, Smith TL, Hwang
PH. Surgical therapy vs continued medical therapy for medically
refractory chronic rhinosinusitis: a systematic review and metaanalysis. Int Forum Allergy Rhinol. 2017;7(2):119-127.
7. Mattos JL, Schlosser RJ, DeConde AS, et al. Factor analysis of
the questionnaire of olfactory disorders in patients with chronic
rhinosinusitis. Int Forum Allergy Rhinol. 2018;8(7):777-782.
8. Rudmik L, Hopkins C, Peters A, Smith TL, Schlosser RJ, Soler
ZM. Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment. J Allergy
Clin Immunol. 2015;136(6):1532-1540.e2.
9. Harel D, Baron M. Methods for shortening patient-reported outcome measures. Statis Methods Med Res. 2018;28(10-11):29923011.
10. Mattos JL, Edwards C, Schlosser RJ, et al. A brief version of the
questionnaire of olfactory disorders in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(10):1144-1150.
11. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical
practice guideline (Update): adult sinusitis executive summary.
Otolaryngol Head Neck Surg. 2015;152(4):598-609.
12. Comrey AL, Lee HB. A First Course in Factor Analysis. 2nd ed.
Mahwah, NJ: Erlbaum; 1992.

7

MATTOS et al.

13. Nunnally J, Bernstein I. Psychometric Theory. 3rd ed. New York:
McGraw-Hill; 1994.
14. McDonald RP. Test Theory: a Unified Treatment. Mahwah, NJ:
Erlbaum; 1999.
15. Muthén LK, Muthén BO. Mplus. Statistical Analysis With Latent
Variables. User’s Guide. Los Angeles, CA: Muthén & Muthén;
2017. https://www.statmodel.com/download/usersguide/Mplus
UserGuideVer_8.pdf. Accessed April 11, 2021.
16. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance
structure analysis: conventional criteria versus new alternatives.
Struct Equ Modeling. 1999;6(1):1-55.
17. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric
validity of the 22-item sinonasal outcome test. Clin Otolaryngol.
2009;34(5):447-454.

18. Simopoulos E, Katotomichelakis M, Gouveris H, Tripsianis G,
Livaditis M, Danielides V. Olfaction-associated quality of life in
chronic rhinosinusitis: adaptation and validation of an olfactionspecific questionnaire. Laryngoscope. 2012;122(7):1450-1454.

How to cite this article: Mattos JL, Bodner TE,
Mace JC, et al. Psychometric properties of the brief
version of the questionnaire of olfactory disorders
in patients with chronic rhinosinusitis. Int Forum
Allergy Rhinol. 2021;1-7.
https://doi.org/10.1002/alr.22800

